CurveBeam AI Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 62

Employees

  • Stock Symbol
  • CVB

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.01
  • (As of Tuesday Closing)

CurveBeam AI General Information

Description

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the companies CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.

Contact Information

Formerly Known As
CurveBeam
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Level 10, 10 Queen Street
  • Melbourne, Victoria 3000
  • Australia
+61 (03)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • Level 10, 10 Queen Street
  • Melbourne, Victoria 3000
  • Australia
+61 (03)

CurveBeam AI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CurveBeam AI Stock Performance

As of 17-Nov-2026, CurveBeam AI’s stock price is $0.01. Its current market cap is $9.9M with 867M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $9.9M 867M 3.59M

CurveBeam AI Financials Summary

As of 30-Sep-2026, CurveBeam AI has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 24,634 17,547 24,325 33,526
Revenue 5,871 7,827 4,277
EBITDA (10,144) (8,660) (12,453)
Net Income (12,757) (10,898) (15,139)
Total Assets 36,629 39,834 42,329
Total Debt 12,145 11,634 10,650
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CurveBeam AI Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CurveBeam AI‘s full profile, request access.

Request a free trial

CurveBeam AI Patents

CurveBeam AI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023274231-B1 Image analysis method and system Active 04-Dec-2023
US-20250182303-A1 Image analysis method and system Active 04-Dec-2023
US-20260141540-A1 Image analysis method and system Pending 04-Dec-2023
US-12536676-B2 Method and system for detecting and correcting misalignment of medical images Active 04-Dec-2023
EP-4539608-A2 Cooled rotating anode x-ray source Pending 10-Oct-2023 H01J35/106
To view CurveBeam AI’s complete patent history, request access »

CurveBeam AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CurveBeam AI Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CurveBeam AI‘s full profile, request access.

Request a free trial

CurveBeam AI Acquisitions (1)

CurveBeam AI’s most recent deal was a Merger/Acquisition with Straxcorp. The deal was made on 20-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Straxcorp 20-Oct-2022 Merger/Acquisition Other Healthcare Technology Systems
To view CurveBeam AI’s complete acquisitions history, request access »

CurveBeam AI ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view CurveBeam AI’s complete esg history, request access »

CurveBeam AI FAQs

  • When was CurveBeam AI founded?

    CurveBeam AI was founded in 2009.

  • Where is CurveBeam AI headquartered?

    CurveBeam AI is headquartered in Melbourne, Australia.

  • What is the size of CurveBeam AI?

    CurveBeam AI has 62 total employees.

  • What industry is CurveBeam AI in?

    CurveBeam AI’s primary industry is Diagnostic Equipment.

  • Is CurveBeam AI a private or public company?

    CurveBeam AI is a Public company.

  • What is CurveBeam AI’s stock symbol?

    The ticker symbol for CurveBeam AI is CVB.

  • What is the current stock price of CurveBeam AI?

    As of 17-Nov-2026 the stock price of CurveBeam AI is $0.01.

  • What is the current market cap of CurveBeam AI?

    The current market capitalization of CurveBeam AI is $9.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process